- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 18.08. | Izalontamab Brengitecan Granted Breakthrough Therapy Designation | ||
| 18.08. | Ifinatamab Deruxtecan Granted Breakthrough Therapy Designation | ||
| 15.08. | FDA Fully Approves Precigen's Papzimeos | ||
| 15.08. | Envirotainer Invests in Swiss Airtainer | ||
| 14.08. | TraceLink Offers New OPUS Platform Capabilities for an AI-Powered Future | ||
| 14.08. | AbbVie to Invest $195M in Chicago Manufacturing Plant | ||
| 13.08. | Phosphorex Names Jerry Williamson as CEO | ||
| 13.08. | Phosphorex, NOF Corporation, NeoSome Life Sciences, NIS, and Envol Biomedical Form the LNP Alliance | ||
| 13.08. | Veranova's Devens Site Passes FDA Inspection | ||
| 13.08. | Bayer, Kumquat Biosciences Partner to Develop & Commercialize KRAS G12D Inhibitor | ||
| 13.08. | Avista, Forge Enter Development & Manufacturing Partnership | ||
| 13.08. | Oxford BioDynamics, Google Cloud Partner to Accelerate Cloud-Based Analytical Frameworks for Precision Medicine | ||
| 13.08. | ElevateBio Receives ICMC Certification for CGT Manufacturing Capabilities | ||
| 13.08. | Bionova Scientific Opens pDNA Development & Production Facility in Texas | ||
| 11.08. | Sartorius Stedim Biotech & Nanotein Technologies to Advance Cell Therapy Manufacturing | ||
| 11.08. | GSK's Gepotidacin Granted Priority Review by U.S. FDA | ||
| 11.08. | FDA Approves Expanded Indication for Celltrion's AVTOZMA | ||
| 11.08. | ProBio Launches cGMP AAV Manufacturing Services at Hopewell, NJ Facility | ||
| 08.08. | CureVac Enters Agreements to Resolve mRNA Patent Litigation with Pfizer/BioNTech? | ||
| 08.08. | Sanner Announces Management Changes | ||
| 07.08. | FDA Approves Jazz Pharmaceuticals Modeyso to Treat Rare Brain Tumor | ||
| 07.08. | Intas and Accord BioPharma Acquire Coherus BioSciences' UDENYCA | ||
| 07.08. | Minghui Pharmaceutical Announces $131 Million Pre-IPO Financing | ||
| 06.08. | Bora Pharmaceuticals to Expand Midwest Manufacturing Site | ||
| 06.08. | Advarra Expands Study Collaboration Technology |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .